Total Holdings
107
Portfolio diversification across 107 positions
SBIO
(NYSEARCA)ALPS Medical Breakthroughs ETF
$63.29-- (--)
Loading... - Market loading
SBIO ETF Holdings: ALPS Medical Breakthroughs ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$206.61M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
SS&C
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 48 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Crinetics Pharmaceuticals, Inc. | Stock | 4.74% |
| 2 |  | Apogee Therapeutics, Inc. | Stock | 4.47% |
| 3 |  | Xenon Pharmaceuticals Inc | Stock | 3.41% |
| 4 |  | CG Oncology, Inc. Common stock | Stock | 3.33% |
| 5 |  | Dianthus Therapeutics, Inc. | Stock | 3.05% |
| 6 |  | Oruka Therapeutics, Inc. | Stock | 2.99% |
| 7 |  | Travere Therapeutics, Inc. | Stock | 2.87% |
| 8 |  | DFTX | Stock | 2.64% |
| 9 |  | Veradermics, Incorporated | Stock | 2.45% |
| 10 |  | Edgewise Therapeutics, Inc. | Stock | 2.36% |
| 11 |  | ACADIA Pharmaceuticals Inc | Stock | 2.29% |
| 12 |  | Relay Therapeutics, Inc | Stock | 2.19% |
| 13 |  | Dyne Therapeutics, Inc. | Stock | 2.17% |
| 14 |  | Denali Therapeutics Inc. | Stock | 1.97% |
| 15 |  | Structure Therapeutics Inc. American Depositary Shares | Stock | 1.89% |
| 16 |  | NewAmsterdam Pharma Company N.V. | Stock | 1.86% |
| 17 |  | Ideaya Biosciences Inc | Stock | 1.69% |
| 18 |  | Vera Therapeutics Inc | Stock | 1.63% |
| 19 |  | MBX Biosciences, Inc. | Stock | 1.58% |
| 20 |  | Celldex Therapeutics Inc | Stock | 1.57% |
| 21 |  | Disc Medicine, Inc. | Stock | 1.52% |
| 22 |  | Immunome, Inc. | Stock | 1.35% |
| 23 |  | Tarsus Pharmaceuticals, Inc. | Stock | 1.35% |
| 24 |  | Sellas Life Sciences Group Inc | Stock | 1.31% |
| 25 |  | BioCryst Pharmaceuticals Inc | Stock | 1.30% |
| 26 |  | Kailera Therapeutics, Inc. Common Stock | Stock | 1.30% |
| 27 |  | Nektar Therapeutics | Stock | 1.29% |
| 28 |  | Mineralys Therapeutics Inc. Common Stock | Stock | 1.26% |
| 29 |  | Agios Pharmaceuticals, Inc | Stock | 1.25% |
| 30 |  | Vericel Corporation | Stock | 1.24% |
| 31 |  | Palvella Therapeutics, Inc | Stock | 1.12% |
| 32 |  | Zai Lab Limited | Stock | 1.11% |
| 33 |  | Viridian Therapeutics Inc | Stock | 1.11% |
| 34 |  | Nuvation Bio Inc | Stock | 1.08% |
| 35 |  | Rapport Therapeutics, Inc. Common Stock | Stock | 1.04% |
| 36 |  | Sionna Therapeutics, Inc. Common Stock | Stock | 1.01% |
| 37 | G GLPG | Galapagos NV ADR | Stock | 1.00% |
| 38 |  | Sarepta Therapeutics, Inc | Stock | 1.00% |
| 39 |  | BCAX | Stock | 0.97% |
| 40 |  | Generate Biomedicines, Inc. Common Stock | Stock | 0.96% |
| 41 |  | Stoke Therapeutics, Inc | Stock | 0.95% |
| 42 |  | Zenas BioPharma, Inc. Common Stock | Stock | 0.95% |
| 43 |  | COMPASS Pathways plc | Stock | 0.95% |
| 44 |  | Immunocore Holdings plc | Stock | 0.90% |
| 45 |  | Maze Therapeutics, Inc. Common Stock | Stock | 0.87% |
| 46 |  | Taysha Gene Therapies, Inc | Stock | 0.86% |
| 47 |  | ArriVent BioPharma, Inc. Common Stock | Stock | 0.80% |
| 48 |  | Corvus Pharmaceuticals Inc | Stock | 0.66% |
Frequently Asked Questions About ALPS Medical Breakthroughs ETF Holdings
What are the top holdings in SBIO?
ALPS Medical Breakthroughs ETF (SBIO) holds 107 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is SBIO's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review SBIO's holdings table to analyze concentration risk.
What is SBIO's sector allocation?
The Sector Allocation chart shows how SBIO distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does SBIO invest in?
SBIO's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is SBIO ETF?
SBIO's diversification can be assessed by reviewing its 107 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.